All previous investigations of these biomarkers and CRC risk have included less than 550 CRC cases, with the exception of two studies on adiponectin and leptin in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort, with approximately 1200 cases, reporting null associations after adjusting for BMI27,28. Here, ADIPOQ is linked to colorectal carcinoma.